HomeQuestion

How do you approach the treatment of reflux hypersensitivity in patients on PPI therapy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What patient characteristics guide the selection of a step-up versus a step-down elimination diet strategy in the management of eosinophilic esophagitis?

How would you approach the management of an incidentally detected subcentimeter nodule located just below/adjacent to the GE junction in a patient without Barrett’s, that is found to harbor high-grade dysplasia (HGD) on pathology following EMR?

What surveillance is recommended for a C1M3 segment of columnar-lined esophageal mucosa with repeated biopsies demonstrating columnar metaplasia but no goblet cells/intestinal metaplasia across multiple endoscopies?

In patients with confirmed non-regurgitant GERD and persistent symptoms despite an adequate PPI trial, is repeat Bravo pH monitoring on therapy indicated, or is referral for pH-impedance testing preferred?

In patients with dysphagia and a normal esophagus on endoscopy, when is empiric dilation indicated? Additionally, is EndoFLIP-derived esophageal distensibility useful in guiding this decision?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.